EU regulator promises speedy review of potential COVID-19 drug remdesivir By: Reuters: Company News May 29, 2020 at 06:56 AM EDT The European health regulator said on Friday its panel would conduct a speedy review of the potential COVID-19 drug, remdesivir. Read More >> Related Stocks: Gilead Sciences